MedPath

Superficial, Cervical Block in Thyroid Surgery, a Randomized Controlled Trial

Phase 2
Completed
Conditions
Thyroidectomy
Interventions
Drug: placebo bilateral superficial cervical block
Drug: bilateral superficial cervical block
Registration Number
NCT00472446
Lead Sponsor
Cantonal Hospital of St. Gallen
Brief Summary

The study investigates the impact on post-operative pain of the superficial cervical block with bupivacaine combined with subcutaneous infiltration of the incisional area in thyroid surgery under general anesthesia. In addition, cost savings using the cervical block are evaluated (due to reduced length of hospital stay).

The study is prospective, randomized, double blind, and placebo-controlled. The study is performed at the Department of Surgery, Cantonal Hospital of St. Gallen.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
183
Inclusion Criteria
  • Elective thyroid or combined thyroid/parathyroid surgery, restricted to the central cervical compartment
  • Informed consent
Exclusion Criteria
  • Intolerance to used medication
  • Recurrent disease
  • Neck dissection, sternotomy
  • Emergency surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
placebo cervical block after surgeryplacebo bilateral superficial cervical blockplacebo bilateral superficial cervical block with saline, placed after surgery (just after skin closure)
cervical block after surgerybilateral superficial cervical blockbilateral superficial cervical block, placed after surgery (just after skin closure)
cervical block before surgerybilateral superficial cervical blockbilateral superficial cervical block, placed before surgery (just before skin incision)
placebo cervical block before surgeryplacebo bilateral superficial cervical blockplacebo bilateral superficial cervical block with saline, placed before surgery (just before skin incision)
Primary Outcome Measures
NameTimeMethod
Post-operative Pain Measured by Visual Analogue Scale6 hours after surgery

Patient administered Instrument to indicate pain on a level from 0 to 10. (0: no pain, 10: worst imaginable pain)

Pooled Relative Treatment Effect of VAS4 days after surgery

Pain was obtained using the visual analog scale (VAS) three times daily for the 4 postoperative days (0 = no pain, 10 = worst imaginable pain)

The pooled relative treatment effect is the probability of values being higher in one group than in another group (ranging from 0 to 1)

Secondary Outcome Measures
NameTimeMethod
Consumption of Post-operative Analgetics5 days after surgery

number of participants taking post-operative analgetics

Mean Consumption of Post-operative Analgetics5 days after surgery

mean pooled dose of post-operative analgetics

Post-operative Pain Measured by Visual Analogue Scale24 hours after surgery

Patient administered Instrument to indicate pain on a level from 0 to 10. (0: no pain, 10: worst imaginable pain)

Hospital Stay90 days

time from surgery to Hospital release in days

Trial Locations

Locations (1)

Department of Surgery, Cantonal Hospital of St. Gallen

🇨🇭

St. Gallen, Switzerland

Department of Surgery, Cantonal Hospital of St. Gallen
🇨🇭St. Gallen, Switzerland
© Copyright 2025. All Rights Reserved by MedPath